Brookfield Corp. price target raised to $75 from $74 at TD Securities
TD Securities raised the firm’s price target on Brookfield Corp. (BN) to $75 from $74 and keeps a Buy rating on the shares as part of a Q4 ...
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist
Truist raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $460 and keeps a Buy rating on the shares. The firm is ...